Grass-Roots Approach To U.S.-Soviet Joint Science Will Sprout Slowly

WASHINGTON—Despite applause from both sides, Soviet and U.S. scientists may be slow to take advantage of two new agreements for joint research. The agreements call on scientists to set up their own collaborations and to find their own funding. Many Soviet scientists are not used to doing this, officials from the National Science Foundation learned during a recent tour of Soviet institutes. “They seem to have some reservations about how this kind of system would work and how it

Written byElizabeth Pennisi
| 4 min read

Register for free to listen to this article
Listen with Speechify
0:00
4:00
Share

WASHINGTON—Despite applause from both sides, Soviet and U.S. scientists may be slow to take advantage of two new agreements for joint research. The agreements call on scientists to set up their own collaborations and to find their own funding. Many Soviet scientists are not used to doing this, officials from the National Science Foundation learned during a recent tour of Soviet institutes.

“They seem to have some reservations about how this kind of system would work and how it would be of benefit to scientific research in their field,” says Gershon Sher, senior program manager in NSF’s division of international programs.

The two agreements, signed May 6, give U.S. and Soviet scientists a chance to submit joint proposals to their respective funding agencies (The Scientist, June 12, 1989, page 2). One agreement, between NSF and the Soviet Academy of Sciences, covers eight disciplines, including mathematics and science policy. The second, ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies